Ventas (NYSE:VTR)‘s stock had its “hold” rating reaffirmed by research analysts at Jefferies Group in a research note issued on Tuesday. They presently have a $54.00 target price on the real estate investment trust’s stock. Jefferies Group’s price objective suggests a potential upside of 6.45% from the stock’s current price.
A number of other analysts have also recently commented on VTR. SunTrust Banks set a $55.00 price target on shares of Ventas and gave the company a “hold” rating in a research note on Friday. Wells Fargo & Co set a $54.00 price objective on shares of Ventas and gave the company a “hold” rating in a research report on Tuesday. Mizuho set a $53.00 price objective on shares of Ventas and gave the company a “hold” rating in a research report on Friday. ValuEngine lowered shares of Ventas from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, BMO Capital Markets set a $55.00 price objective on shares of Ventas and gave the company a “sell” rating in a research report on Friday. Eight investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. Ventas presently has a consensus rating of “Hold” and an average target price of $58.31.
Shares of Ventas (NYSE:VTR) traded up $0.27 during mid-day trading on Tuesday, reaching $50.73. 2,468,163 shares of the company’s stock were exchanged, compared to its average volume of 3,079,577. The firm has a market capitalization of $18,010.00 and a PE ratio of 28.58. The company has a current ratio of 1.20, a quick ratio of 1.46 and a debt-to-equity ratio of 1.03. Ventas has a 12-month low of $49.17 and a 12-month high of $72.36.
A number of large investors have recently added to or reduced their stakes in VTR. Valeo Financial Advisors LLC increased its position in Ventas by 1,945.6% during the fourth quarter. Valeo Financial Advisors LLC now owns 1,841 shares of the real estate investment trust’s stock worth $110,000 after acquiring an additional 1,751 shares during the period. Aevitas Wealth Management Inc. bought a new position in Ventas during the fourth quarter worth about $114,000. Icon Wealth Partners LLC bought a new position in Ventas during the fourth quarter worth about $114,000. Amica Retiree Medical Trust bought a new position in Ventas during the third quarter worth about $131,000. Finally, CENTRAL TRUST Co increased its position in Ventas by 85.7% during the fourth quarter. CENTRAL TRUST Co now owns 2,357 shares of the real estate investment trust’s stock worth $141,000 after acquiring an additional 1,088 shares during the period. 90.05% of the stock is currently owned by institutional investors and hedge funds.
Ventas Company Profile
Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.